Terumo Corporation, based in Tokyo, Japan, manufactures and supplies pharmaceuticals and medical equipment globally. Founded in 1921, the company offers a wide range of products including intravenous catheters, infusion sets, artificial heart and lungs, blood glucose and pressure monitoring systems, blood transfusion-related products, oncology safety products, and peripheral stents. Terumo markets its products through subsidiaries and sales offices in the US, Europe, and Asia.
Terumo has made significant contributions to the medical field, becoming a key player in the industry. It is publicly traded on the Tokyo Stock Exchange under the ticker TYO: 4543 and is a component of the Nikkei 225. The company is led by Chairman Takayoshi Mimura and President Shinjiro Sato. Terumo's innovations and extensive product line have had a substantial impact on healthcare globally.
